Clinical trial
An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic…
NCT00095056 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00095056 |
|---|---|
| Title | An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED) |
| Official title | Sitagliptin Study in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2, Chronic Renal Insufficiency |
| Intervention type | Drug |
| Interventions | sitagliptin, Placebo to Sitagliptin, glipizide, Placebo to glipizide |
| Enrollment | 91 |
| Start date | Oct 1, 2004 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Nov 1, 2004 |
| Last update posted | Apr 2, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: